PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 18, 2016Heart45 citationsOpen Access

Meta-analysis of the impact of intervention versus symptom-driven management in asymptomatic severe aortic stenosis

View Full Paper
WLWei Yao LimARAnantharaman RamasamyGLGuy Lloyd

Key Result

Early AVR in asymptomatic severe aortic stenosis showed a non-significant trend towards reduced overall mortality compared with a symptom-driven approach (OR 0.54; 95% CI 0.26 to 1.12; p=0.1).

Key Points

  • To evaluate the impact on clinical outcomes of early aortic valve replacement versus a symptom-driven intervention approach in patients with asymptomatic severe aortic stenosis.
  • Conducted a systematic review and meta-analysis of four observational studies including a total of 1300 patients with asymptomatic severe aortic stenosis.
  • Evaluated endpoints of all-cause mortality, cardiac mortality, and sudden cardiac death comparing early aortic valve replacement (AVR) to a symptom-driven AVR approach using a random-effects model.
  • Early AVR showed a nonsignificant trend toward reduced all-cause mortality compared with a symptom-driven approach (OR 0.54, 95% CI 0.26 to 1.12, p=0.10) with marked heterogeneity across studies (I²=72%).
  • No statistically significant difference occurred between strategies for cardiac mortality (OR 0.78, p=0.85) or sudden cardiac death (OR 0.34, p=0.25).

Study Design

Type

Meta-Analysis (n=1,300)

Structured PICO

Does early AVR reduce mortality compared to symptom-driven management in patients with asymptomatic severe aortic stenosis?

P
Population
1300 patients with asymptomatic severe aortic stenosis from 4 observational studies
I
Intervention
Early aortic valve replacement (AVR)
C
Comparator
Symptom-driven AVR approach (excluding symptomatic patients who did not undergo AVR)
O
Outcome
All-cause mortalityhard clinical

Early AVR in asymptomatic severe aortic stenosis showed a non-significant trend toward reduced overall mortality compared to symptom-driven management, highlighting the need for randomized trials.

Main Result

Effect estimate: OR 0.54 (95% CI 0.26 to 1.12)

p-value: p=0.1

Limitations

  • Significant heterogeneity between studies (I2=72%)
  • Lack of robust, randomised trial data
  • Significant heterogeneity between studies (I²=72%)

Abstract

Objective The management of patients with asymptomatic, severe aortic stenosis (AS) is controversial. We performed a meta-analysis to examine the impact on outcomes of aortic valve replacement (AVR) in patients with severe asymptomatic AS versus a symptom-driven intervention approach. Methods A search for studies that examined the outcomes of AVR and management of asymptomatic severe AS was performed. We examined the end points of all-cause mortality, cardiac mortality and sudden cardiac death. Our analysis compared early AVR in asymptomatic patients with a symptom-driven AVR approach (excluding symptomatic patients who did not undergo AVR). Results Four observational studies were identified with a total of 1300 patients. There was significant heterogeneity between studies (I 2 =72%). Using a random-effects model, there was a trend towards reduced overall mortality in patients undergoing early AVR compared with a symptom-driven AVR approach (OR 0.54, 95% CI 0.26 to 1.12, p=0.1). There was no significant reduction in cardiac mortality or sudden death (OR 0.78, p=0.85, and OR 0.34, p=0.25, respectively). Conclusions Although there was a trend towards reduced overall mortality when comparing early AVR in patients with asymptomatic, severe AS to a symptom-driven AVR approach, there was no significant difference in cardiac mortality or sudden death. An individual approach focusing on individual risk stratification and operative mortality is required until more robust, randomised trial data are available.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lim et al. (2016) conducted a meta-analysis in asymptomatic severe aortic stenosis (n=1,300). Early aortic valve replacement (AVR) vs. Symptom-driven AVR approach was evaluated on all-cause mortality (OR 0.54, 95% CI 0.26 to 1.12, p=0.1). Early AVR in asymptomatic severe aortic stenosis showed a non-significant trend towards reduced overall mortality compared with a symptom-driven approach (OR 0.54; 95% CI 0.26 to 1.12; p=0.1).

synapsesocial.com/papers/6a0a593997b2cd65685918a6https://doi.org/10.1136/heartjnl-2016-309830
Ask AI
Helpful
Bookmark
Share
View Full Paper